-
J EUR ACAD DERMATOL: DERMOSCOPY AND CONFOCAL PREDICTIVE DIAGNOSIS OF NONPIGMENTED OR HYPOCHROMIC MALIGNANT LENTIFORM NEVI
Time of Update: 2022-10-26
▎Research protocol:The patient has AHLM/LMM, apigmented or hypochromic benign lesions (AHBL), non-pigmented or hypochromic basal and squamous cell carcinoma (AHBCC/AHSCC) on the head or neck, confirmed by pathological tissue examination by dermoscopy and RCM imaging.
-
Nature Methods: Find antigens that trigger specific immune cells faster and more accurately
Time of Update: 2022-09-14
essaybead-based method for high-throughput mapping of the sequence- and force-dependence of T cell activation The secret of a cell can be revealed from its surface, which is decorated with tens of thousands to hundreds of thousands of molecules, helping immune cells distinguish between enemies and enemies.
-
Highlights of "Cell": Prevent vision loss
Time of Update: 2021-09-05
▲The optic nerve composed of axons of retinal ganglion cells transmits visual signals to the brain's visual processing center (picture source: reference material [3]; Credit: National Eye Institute)"In order to preserve vision, we urgently need strategies that can protect nerves to retain fragile retinal ganglion cells .
-
Stroke: The relationship between cerebral hemodynamics and executive function in patients with sickle cell anemia
Time of Update: 2021-05-20
do?w=%E5%BF%83%E8%A1%80%E7%AE%A1">heart blood vessels published a research article on the disease areas prestigious journal Stroke, the study aims to test the following hypothesis: sickle cell anemia in patients with cerebral blood flow and oxygen extraction fraction increases associated with lower executive function.
-
Cell Journal: Wang Rongfu's team confirmed that this intestinal strain can inhibit colon cancer
Time of Update: 2021-05-09
On April 23, 2021, the team of Professor Rongfu Wang from the Keck School of Medicine of the University of Southern California published a research paper entitled: Microbiota regulate innate immune signaling and protective immunity against cancer in the journal Cell Host & Microbe.
-
Empowering "anti-tumor warrior" T-cells
Time of Update: 2021-03-11
Molecular Cell Science Innovation Center for Excellence (Bioindustification and Cell Institute, referred to as the Center for Molecular Cell Excellence) Xu Wei team, Peking University Medical Department Huang Chaolan team and the University of California, San Diego Whinf team, from the basic research of T cell signal transduce, developed a new method of CAR-T cell therapy.
-
Scientists analyze in depth the basic molecular mechanisms of self-renewal and differentiation of intestinal stem cells
Time of Update: 2021-02-11
Using professional terminology, the researchers were able to describe a detailed intestinal stem cell line tree and identify a new habitat signal, and to achieve these breakthrough results, the researchers used different reported mouse linelogies, combined with genome-wide and targeted single-cell gene expression analysis, to time-resolution genealogy markers for rare intestinal linelogies, and to analyze genealogical decision-making mechanisms for intestinal stem cells.
-
Scientists illustrate the key role of alkaline granulocytes in lung development
Time of Update: 2021-02-06
Adults' lungs are made up of many highly specific cell types that are protected by a variety of immune cells, so how do these immune cells migrate to the lungs after birth and during development? How
-
A new combination therapy may help the immune system better attack cancer
Time of Update: 2021-01-29
Working in mice, a team led by Jamey Weichert, professor of radiology, and Zachary Morris, professor of human oncology, is combining two different techniques in its approach, using targeted radionuclide therapy, which delivers a low dose of cell-weakening radiation specifically to cancer cells, followed by immunotherapy, which helps the immune system to recognize and destroy cancer cells.
-
STEM CELLS Translational Medicine: Breakthroughs have been made in the treatment of severe COVID-19 with interstitiotic stem cells
Time of Update: 2021-01-24
30-day survival rate was 91 percent for patients in the stem cell therapy group, compared with 42 percent for the control group.
30 days, more than 80 percent of patients in the treatment group recovered, compared with less than 37 percent in the control group.
-
Belgian scientists discover new antibody to curb tumor growth
Time of Update: 2020-07-06
Researchers at the university's Hospital in Leffen, Belgium, recently discovered a new antibody that curbs the growth of tumors , with the advantage of having few side effects and could be applie
